Moderna efficacy is ‘really exciting’: TGA

The Therapeutic Goods Administration’s Professor John Skerritt says the Moderna vaccine is proving to be incredibly effective against COVID-19 and variants.

“We’re delighted to have provided regulatory approval to the Moderna vaccine in the last hour,” Professor Skerritt said.

“Even after six months, it’s proving to be 93 per cent efficacious against any infection, 98 per cent against severe disease and 100 per cent against death, and that’s really exciting.

“It’s very exciting to see such sustained activity of that vaccine six months after.”